Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial

DOI: 10.1038/s41531-018-0071-3

Full-Text   Cite this paper   Add to My Lib

Abstract:

Overview of trial profil

Full-Text